Shannon H E, Holtzman S G
Eur J Pharmacol. 1976 Oct;39(2):295-303. doi: 10.1016/0014-2999(76)90139-4.
The capacity of the narcotic antagonists naloxone and nalorphine and the benzodiazepine derivatives diazepam and oxazepam to increase the LD50s of the narcotic analgesics morphine and methadone administered at convulsant doses was eveluated in the mouse. Naloxone produced a dose-related increase in the LD50s of both morphine and methadone. Iiazepam and oxazepam were also effective in increasing the LD50s of the narcotics; this effect was additive with that of naloxone. However, the maximal increase in the LD50s of the narcotics produced by pretreatment with naloxone alone was not increased further by the combined pretreatment of naloxone and a benzodiazepine. The anticonvulsant trimethadione did not elevate the LD50s of methadone, nor did it potentiate the effects of naloxone. These results suggest that the benzodiazepines may reduce the lethality of narcotic analgesics administered at high doses by a mechanism other than by an anticonvulsant effect alone. Therefore, the present results support the conclusion that the capacity to increase the convulsant LD50 of the narcotic analgesics is a general property of the narcotic antagonists.
在小鼠中评估了麻醉拮抗剂纳洛酮和烯丙吗啡以及苯二氮䓬衍生物地西泮和奥沙西泮增加惊厥剂量的麻醉性镇痛药吗啡和美沙酮半数致死量(LD50)的能力。纳洛酮使吗啡和美沙酮的LD50呈剂量相关增加。地西泮和奥沙西泮也能有效增加麻醉药的LD50;这种作用与纳洛酮的作用相加。然而,单独用纳洛酮预处理使麻醉药LD50的最大增加量,并未因纳洛酮与苯二氮䓬联合预处理而进一步增加。抗惊厥药三甲双酮既未提高美沙酮的LD50,也未增强纳洛酮的作用。这些结果表明,苯二氮䓬类药物可能通过并非仅为抗惊厥作用的其他机制降低高剂量麻醉性镇痛药的致死性。因此,目前的结果支持以下结论:增加麻醉性镇痛药惊厥LD50的能力是麻醉拮抗剂的普遍特性。